BioMarin Pharmaceutical (BMRN) Financials: Revenue & Earnings
BMRN$55.74+0.39 +0.70%
$10.79B
Market Cap
146.71
P/E
15.77
Forward P/E
52
Score
BioMarin Pharmaceutical (BMRN) Financials: Revenue & Earnings
BMRN price $55.74 +0.39 +0.70%
- Ticker
- BMRN
- Price
- $55.74
- Change
- +0.39 +0.70%
- Market cap ?
- $10.79B
- P/E ?
- 146.71
- Forward P/E ?
- 15.77
- Dividend yield ?
- 0.00%
- Beta ?
- 0.21
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 52
- Value
- 56
- Quality
- 48
- Growth
- 51
Stocklytics score rationale: value 56, quality 48, growth 51.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1116854000 | 1313646000 | 1491256000 | 1704048000 | 1860455000 | 1846275000 | 2096039000 | 2419226000 | 2853915000 | 3221253000 |
BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage disorder, and Naglazyme…
Fair value
BMRN fair value $173.06. Price $55.74. Price is 68% below fair value.
Below fair value, and cheaper than usual. A larger discount than on 87% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 732.88M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 193.57M. Net debt -668.81M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | -0.08 | — | 1.02B |
| 2026-08-06 | 1.20 | 0.95 | 989.71M | 932.03M |
| 2026-05-04 | 0.76 | 0.78 | 766.00M | 752.53M |
| 2026-02-23 | -0.24 | 0.17 | 874.57M | 833.73M |
| 2025-10-27 | -0.16 | -0.15 | 776.13M | 777.48M |
| 2025-08-04 | 1.23 | 0.86 | 825.00M | 761.95M |
| 2025-05-01 | 0.97 | 0.71 | 745.14M | 738.66M |
| 2025-02-19 | 0.64 | 0.54 | 747.00M | 712.30M |
| 2024-10-29 | 0.55 | 0.53 | 745.74M | 703.43M |
| 2024-08-05 | 0.55 | 0.36 | 712.03M | 663.98M |
| 2024-04-24 | 0.46 | 0.31 | 648.80M | 651.83M |
| 2024-02-22 | 0.11 | 0.20 | 646.21M | 638.82M |
| 2023-11-01 | 0.21 | 0.22 | 581.33M | 603.84M |
| 2023-07-31 | 0.29 | 0.21 | 595.27M | 595.23M |
| 2023-04-26 | 0.27 | 0.16 | 596.41M | 570.35M |
| 2023-02-27 | 0.11 | -0.07 | 537.54M | 537.62M |
| 2022-10-26 | -0.04 | -0.01 | 505.34M | 518.45M |
| 2022-08-03 | 0.15 | 0.03 | 533.80M | 520.20M |
| 2022-04-27 | 0.63 | 0.21 | 519.36M | 510.95M |
| 2022-02-23 | -0.32 | -0.36 | 449.81M | 442.38M |
| 2021-10-27 | -0.20 | -0.25 | 408.74M | 436.53M |
| 2021-07-28 | 0.23 | 0.30 | 501.69M | 437.06M |
| 2021-04-29 | 0.10 | -0.07 | 486.03M | 447.62M |
| 2021-02-25 | 0.12 | -0.17 | 452.12M | 1.07B |
| 2020-11-05 | 4.01 | 0.25 | 476.78M | 147.43M |
| 2020-08-04 | -0.16 | -0.10 | 429.49M | 268.43M |
| 2020-04-29 | 0.45 | 0.05 | 502.04M | 57.05M |
| 2020-02-26 | 0.08 | -0.04 | 454.44M | 340.83M |
| 2019-10-23 | 0.31 | 0.06 | 461.10M | 92.22M |
| 2019-08-01 | -0.21 | -0.11 | 387.76M | 294.46M |
| 2019-04-25 | -0.32 | -0.19 | 400.75M | 313.21M |
| 2019-02-21 | -0.07 | 0.10 | 353.21M | 4.42B |
| 2018-10-25 | -0.07 | 0.13 | 391.71M | 1.23B |
| 2018-08-02 | -0.09 | 0.17 | 372.85M | 704.26M |
| 2018-04-25 | -0.25 | 0.13 | 373.45M | 253.94M |
| 2018-02-22 | -0.30 | -0.24 | 358.31M | 284.17M |
| 2017-10-26 | -0.07 | -0.14 | 334.15M | 668.30M |
| 2017-08-02 | -0.21 | -0.22 | 317.45M | 317.45M |
| 2017-05-04 | -0.09 | -0.29 | 303.75M | 944.98M |
| 2017-02-23 | -0.53 | -0.38 | 300.09M | 215.16M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Friberg Gregory R | Sell | 4.09K | $60.00 | 245.16K |
| 2026-09-10 | Plenge Robert M | Buy | 6.14K | — | — |
| 2026-09-10 | Plenge Robert M | Other | 0 | — | — |
| 2026-09-02 | Davis George Eric | Sell | 17.56K | $66.28 | 1.16M |
| 2026-06-02 | Countouriotis Athena | Buy | 7.49K | — | — |
| 2026-06-02 | Walbert Timothy P | Buy | 7.49K | — | — |
| 2026-06-02 | Ho Maykin | Buy | 7.49K | — | — |
| 2026-06-02 | HOMBACH ROBERT J. | Buy | 7.49K | — | — |
| 2026-06-02 | Enyedy Mark J | Buy | 7.49K | — | — |
| 2026-06-02 | Dere Willard H | Buy | 7.49K | — | — |
| 2026-06-02 | CLARK IAN T | Buy | 7.49K | — | — |
| 2026-06-02 | Bodem Barbara W. | Buy | 7.49K | — | — |
| 2026-06-02 | ANDERSON ELIZABETH M | Buy | 7.49K | — | — |
| 2026-05-20 | Hubbard Cristin | Sell | 2.32K | $50.20 | 116.36K |
| 2026-05-07 | Friberg Gregory R | Sell | 3.28K | $53.85 | 176.68K |
| 2026-03-18 | Davis George Eric | Sell | 1.27K | $56.05 | 71.35K |
| 2026-03-17 | Guyer Charles Greg | Sell | 1.69K | $56.05 | 94.89K |
| 2026-03-17 | Mueller Brian | Sell | 2.12K | $56.05 | 118.66K |
| 2026-03-17 | Hardy Alexander | Sell | 4.25K | $56.05 | 238.32K |
| 2026-03-17 | Hubbard Cristin | Sell | 1.25K | $56.05 | 69.78K |
| 2026-03-17 | Friberg Gregory R | Sell | 1.63K | $56.05 | 91.31K |
| 2026-03-16 | Hubbard Cristin | Buy | 15.41K | — | — |
| 2026-03-16 | Hubbard Cristin | Buy | 36.68K | $57.43 | 2.11M |
| 2026-03-16 | Friberg Gregory R | Buy | 19.15K | — | — |
| 2026-03-16 | Friberg Gregory R | Buy | 45.60K | $57.43 | 2.62M |
| 2026-03-16 | Guyer Charles Greg | Buy | 14.99K | — | — |
| 2026-03-16 | Guyer Charles Greg | Buy | 35.68K | $57.43 | 2.05M |
| 2026-03-16 | Davis George Eric | Buy | 14.57K | — | — |
| 2026-03-16 | Davis George Eric | Sell | 7.18K | $58.51 | 419.93K |
| 2026-03-16 | Davis George Eric | Buy | 34.69K | $57.43 | 1.99M |
| 2026-03-16 | Mueller Brian | Buy | 18.74K | — | — |
| 2026-03-16 | Mueller Brian | Buy | 44.60K | $57.43 | 2.56M |
| 2026-03-16 | Hardy Alexander | Buy | 62.44K | — | — |
| 2026-03-16 | Hardy Alexander | Buy | 89.20K | $57.43 | 5.12M |
| 2026-03-13 | Guyer Charles Greg | Sell | 9.11K | $58.51 | 532.97K |
| 2026-03-13 | Mueller Brian | Sell | 9.95K | $58.51 | 581.88K |
| 2026-03-13 | Hardy Alexander | Sell | 2.94K | $58.51 | 172.08K |
| 2026-03-11 | Guyer Charles Greg | Sell | 16.49K | $60.46 | 996.74K |
| 2026-02-26 | Friberg Gregory R | Sell | 6.33K | $60.38 | 381.94K |
| 2026-02-26 | Davis George Eric | Sell | 26.06K | $61.36 | 1.60M |
| 2026-02-25 | Guyer Charles Greg | Buy | 2.37K | — | — |
| 2026-02-25 | Guyer Charles Greg | Buy | 6.67K | — | — |
| 2026-02-25 | Guyer Charles Greg | Buy | 6.18K | — | — |
| 2026-02-25 | Davis George Eric | Buy | 2.37K | — | — |
| 2026-02-25 | Davis George Eric | Buy | 6.67K | — | — |
| 2026-02-25 | Davis George Eric | Buy | 6.18K | — | — |
| 2026-02-25 | Mueller Brian | Buy | 2.57K | — | — |
| 2026-02-25 | Mueller Brian | Buy | 7.23K | — | — |
| 2026-02-25 | Mueller Brian | Buy | 6.68K | — | — |
| 2026-01-20 | Ramchandani Rashmi Virendra | Buy | 7.07K | — | — |
| 2026-01-20 | Ramchandani Rashmi Virendra | Buy | 18.54K | — | — |
| 2026-01-20 | Ramchandani Rashmi Virendra | Buy | 18.22K | $56.31 | 1.03M |
| 2026-01-20 | Ramchandani Rashmi Virendra | Other | 0 | — | — |
| 2025-12-31 | Mueller Brian | Other | 0 | — | — |
| 2025-12-31 | MEIER RICHARD A | Other | 0 | — | — |
| 2025-12-31 | Hubbard Cristin | Other | 0 | — | — |
| 2025-12-31 | Guyer Charles Greg | Other | 0 | — | — |
| 2025-12-31 | Friberg Gregory R | Other | 0 | — | — |
| 2025-12-31 | Davis George Eric | Other | 0 | — | — |
| 2025-12-30 | MEIER RICHARD A | Sell | 500 | — | — |
| 2025-12-01 | Hardy Alexander | Sell | 16.57K | $55.03 | 911.85K |
| 2025-10-31 | Hubbard Cristin | Buy | 80 | $45.53 | 3.64K |
| 2025-10-31 | Guyer Charles Greg | Buy | 62 | $45.53 | 2.82K |
| 2025-10-31 | Friberg Gregory R | Buy | 398 | $45.53 | 18.12K |
| 2025-09-30 | Friberg Gregory R | Sell | 3.30K | $54.16 | 178.94K |
| 2025-08-01 | CLARK IAN T | Buy | 7.00K | — | — |
| 2025-08-01 | CLARK IAN T | Other | 0 | — | — |
| 2025-05-20 | Hubbard Cristin | Sell | 2.15K | $59.93 | 129.15K |
| 2025-05-20 | Walbert Timothy P | Buy | 6.65K | — | — |
| 2025-05-20 | MEIER RICHARD A | Buy | 6.65K | — | — |
| 2025-05-20 | HOMBACH ROBERT J. | Buy | 6.65K | — | — |
| 2025-05-20 | Ho Maykin | Buy | 6.65K | — | — |
| 2025-05-20 | Enyedy Mark J | Buy | 6.65K | — | — |
| 2025-05-20 | Dere Willard H | Buy | 6.65K | — | — |
| 2025-05-20 | Countouriotis Athena | Buy | 6.65K | — | — |
| 2025-05-20 | Bodem Barbara W. | Buy | 6.65K | — | — |
| 2025-05-20 | ANDERSON ELIZABETH M | Buy | 6.65K | — | — |
| 2025-05-20 | Burkhart Erin | Sell | 1.79K | $59.31 | 105.93K |
| 2025-05-19 | Burkhart Erin | Sell | 996 | $59.27 | 59.03K |
| 2025-05-02 | Hubbard Cristin | Sell | 273 | $64.92 | 17.72K |
| 2025-04-30 | Mueller Brian | Buy | 375 | $54.14 | 20.30K |
| 2025-04-30 | Guyer Charles Greg | Buy | 317 | $54.14 | 17.16K |
| 2025-04-30 | Davis George Eric | Buy | 375 | $54.14 | 20.30K |
| 2025-04-30 | Hardy Alexander | Buy | 375 | $54.14 | 20.30K |
| 2025-04-30 | Hubbard Cristin | Buy | 273 | $54.14 | 14.78K |
| 2025-03-19 | Burkhart Erin | Sell | 1.29K | $71.52 | 92.62K |
| 2025-03-17 | Burkhart Erin | Buy | 5.97K | — | — |
| 2025-03-17 | Burkhart Erin | Buy | 9.23K | $71.55 | 660.41K |
| 2025-03-17 | Davis George Eric | Buy | 12.94K | — | — |
| 2025-03-17 | Davis George Eric | Buy | 30.02K | $71.55 | 2.15M |
| 2025-03-17 | Hubbard Cristin | Buy | 13.31K | — | — |
| 2025-03-17 | Hubbard Cristin | Buy | 30.88K | $71.55 | 2.21M |
| 2025-03-17 | Friberg Gregory R | Buy | 17.75K | — | — |
| 2025-03-17 | Friberg Gregory R | Buy | 41.17K | $71.55 | 2.95M |
| 2025-03-17 | Guyer Charles Greg | Buy | 13.31K | — | — |
| 2025-03-17 | Guyer Charles Greg | Buy | 30.88K | $71.55 | 2.21M |
| 2025-03-17 | Mueller Brian | Buy | 16.64K | — | — |
| 2025-03-17 | Mueller Brian | Buy | 38.59K | $71.55 | 2.76M |
| 2025-03-17 | Hardy Alexander | Buy | 44.36K | — | — |
| 2025-03-17 | Hardy Alexander | Buy | 61.75K | $71.55 | 4.42M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 587, holders +2 vs prior quarter. Ownership 101.34%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 20.45M | 626.91K | +3.16% | 1.17B |
| DODGE & COX | 14.84M | 283.17K | +1.94% | 849.43M |
| PRIMECAP MANAGEMENT CO/CA/ | 14.19M | -3.82K | -0.03% | 811.96M |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.74M | 100.47K | +1.16% | 500.31M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.65M | 350.20K | +4.22% | 494.88M |
| NORGES BANK | 8.21M | 8.21M | New | 469.66M |
| STATE STREET CORP | 7.80M | 505.88K | +6.93% | 446.37M |
| VIKING GLOBAL INVESTORS LP | 7.62M | 554.49K | +7.85% | 435.82M |
| VESTAL POINT CAPITAL, LP | 6.03M | 2.45M | +68.53% | 344.75M |
| AQR CAPITAL MANAGEMENT LLC | 5.70M | -1.98M | -25.75% | 322.54M |
| FMR LLC | 4.82M | 1.26M | +35.21% | 275.97M |
| DIMENSIONAL FUND ADVISORS LP | 4.08M | 272.78K | +7.17% | 233.22M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.91M | 92.35K | +2.42% | 223.89M |
| CAPITAL RESEARCH GLOBAL INVESTORS | 3.50M | 13.00K | +0.37% | 200.52M |
| DEEP TRACK CAPITAL, LP | 3.31M | 2.16M | +187.61% | 189.25M |
| MILLENNIUM MANAGEMENT LLC | 2.07M | -938.49K | -31.18% | 118.55M |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.76M | -158.57K | -8.26% | 100.83M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.62M | 28.34K | +1.78% | 92.47M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.62M | 1.62M | New | 92.47M |
| FIRST TRUST ADVISORS LP | 1.61M | -66.22K | -3.96% | 91.91M |
| NORTHERN TRUST CORP | 1.56M | -28.28K | -1.78% | 89.15M |
| MORGAN STANLEY | 1.50M | 183.32K | +13.87% | 86.12M |
| JONES HILL CAPITAL LP | 1.43M | 163.20K | +12.87% | 81.92M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.33M | 481.28K | +56.52% | 76.26M |
| SWEDBANK AB | 1.31M | 522.60K | +65.97% | 75.23M |
Earnings and financials
BioMarin Pharmaceutical Inc. (BMRN) trades at $55.74, with a market cap of $10.79B and a trailing P/E of 146.71. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1116854000 | 1313646000 | 1491256000 | 1704048000 | 1860455000 | 1846275000 | 2096039000 | 2419226000 | 2853915000 | 3221253000 |
Insights · Dividends · Forecast · Financials · Learn